ALMIRALL, S.A. «...1112131415...» Page 12 out of 18 26/07/2021 06:47 ALMIRALL, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2021 Register number: 10794 26/07/2021 06:45 ALMIRALL, S.A. On business and financial situation First semester results presentation 2021 Register number: 10793 26/07/2021 06:38 ALMIRALL, S.A. On business and financial situation Almirall announces that will make a presentation to comment on the results for the first half of 2021. Register number: 10792 19/07/2021 15:00 ALMIRALL, S.A. On business and financial situation Almirall receives European Commission approval for Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis Register number: 10690 06/07/2021 17:39 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el segundo trimestre de 2021 Register number: 10512 01/07/2021 10:34 ALMIRALL, S.A. Total number of voting rights and capital Acciones nuevas de la Sociedad creadas como consecuencia del aumento de capital liberado a través del cual se instrumenta el programa de dividendo flexible de la Sociedad Register number: 10356 01/07/2021 08:24 ALMIRALL, S.A. On corporate transactions Almirall and Kaken Pharmaceutical enter into a License and Distribution Agreement for European Rights to the topical formulation of efinaconazole Register number: 10352 18/06/2021 14:35 ALMIRALL, S.A. Announcement of general shareholders’ meeting Acuerdos de la Junta General Extraordinaria de Accionistas de la Sociedad Register number: 10091 11/06/2021 10:58 ALMIRALL, S.A. Other relevant information - On corporate governance Almirall appoints Dr. Karl Ziegelbauer as the new Chief Scientific Officer Register number: 9932 11/06/2021 07:53 ALMIRALL, S.A. Other relevant information La Sociedad comunica información relativa al dividendo flexible: admisión a cotización de acciones Register number: 9928 Page 12 out of 18 «...1112131415...»
